Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Coronavirus (19) is a pandemic that affects many countries allover the world. Many patients experienced symptoms as dyspnea and fatigue after their recovery from coronavirus . These symptoms appear to occur regardless the severity of the infection. In addition, many studies reported change in the inflammatory status and immunity in post covid patients. laser acupuncture is a painless noninvasive modality that is used in treating many diseases. laser acupuncture appear to have a role in relieving symptoms, altering inflammatory status and boosting immunity in post covid patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| group(1) | Active Comparator | 40 post covid 19 patients will receive laser acupuncture |
|
| group(2) | Placebo Comparator | 40 post covid patients will receive placebo laser acupuncture in which laser will be off |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| laser acupuncture | Device | gallium-aluminum arsenide diode laser with a continuous wave and a wavelength of 850nm will be used for laser acupuncture. it will be applied for three times per week for 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| change in the level of CD 3 T cells | 5ml of blood will be drawn and serum will be separated. cd3 level will be measured using BD FACS Canto flow cytometer | after 12 weeks of treatment |
| change in the level of cd4 T cells | cd4 will be measured using BD FACS Canto flow cytometer after blood sample will be separated | after 12 weeks of treatment |
| change in level of interleukin 4 | BD FACS Canto flow cytometer with BD CBA human th1/th2 cytokine kit will be used | after 12 weeks of treatment |
| change in level of interleukin 6 | BD FACS Canto flow cytometer with BD CBA human th1/th2 cytokine kit will be used | after 12 weeks of treatment |
| change in lymphocyte count | BD FACS Canto flow cytometer will be used | after 12 weeks of treatment |
| change in level of dyspnea | mMRC scale is a five point scale to detect degree of dyspnea while performing physical activity. it is ranged from 0-4 | after 12 weeks of treatment |
| Measure | Description | Time Frame |
|---|---|---|
| change in fatigability | chalder fatigue scale is 11 items scale. people of 4 or more are considered meeting the criteria of fatigue | after 12 weeks of treatment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| salma alghitany, PHD degree | Contact | 00201229723881 | fardreams@yahoo.com | |
| sandra girguis, PHD degree | Contact | 00201221426663 | sandra_sweety@hotmail.com |
| Name | Affiliation | Role |
|---|---|---|
| shawky fouad, PHD degree | Cairo University | Principal Investigator |
| sandra girguis, PHD degree | Cairo University | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided